Melatonin is an indoleamine often used for the treatment of primary and secondary insomnia in children and adolescents. Its hypnotic effect seems to be related to both, the reduction of the cortical activation, and the inhibition of the neural system responsible for the alertness. Goals of this study are to clarify the utility and safety of melatonin use in paediatric population and in adition to determine the dosage and the time of more effectiveness of melatonin administration in children and adolescents with primary sleep disorders and those associated with neurodevelopmental disorders.
